查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1844171

手動人工呼吸器市場按最終用戶、產品類型、營運模式和銷售管道分類—2025-2032 年全球預測

Manual Resuscitators Market by End User, Product Type, Mode Of Operation, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年手動人工呼吸器市場規模將成長至 9.9363 億美元，複合年成長率為 7.54%。

主要市場統計數據
基準年2024年 5.5512億美元
預計2025年 5.9754億美元
預測年份：2032年 9.9363億美元
複合年成長率（%） 7.54%

確定手動人工呼吸器在現代急診和住院護理途徑中的作用，並確定採購和臨床可用性的優先事項

手動人工呼吸器市場正處於臨床緊急程度、製造標準和不斷發展的醫療保健系統期望的交匯點，這給醫療保健提供者、經銷商和製造商的決策者帶來了挑戰，使他們必須清晰地了解情況。手動人工呼吸器仍然是醫療保健環境中用於即時呼吸道管理和呼吸支援的核心關鍵干預設備，而近期臨床指南、滅菌方法和採購管道的變化也增加了對嚴謹資訊的需求。本介紹將該設備置於現代護理路徑和供應鏈的現實中，同時強調性能、易用性和法規合規性是其被廣泛採用的關鍵決定因素。

在各種護理環境中，手動人工呼吸器的評估不僅基於其即時救生能力，還基於其人體工學、材料成分以及與輔助設備的兼容性。採購團隊目前正在權衡耐用性、再處理要求、最終用戶偏好以及在各種使用條件下保障患者安全的需求。同時，設備製造商必須應對複雜的監管環境，並結合臨床醫生的回饋，改善設計、材料和標籤，從而提高有效性和易用性。

本節為深入探討影響供需的系統性變化奠定了基礎。本章指出，人工呼吸器是高階通氣支持的重要臨床補充，也是災難準備的關鍵組成部分。透過闡明臨床角色、營運限制和採購考慮因素，本引言將幫助讀者理解後續對政策影響、細分市場細微差別、區域動態以及產業相關人員策略反應的分析。

材料創新、法規收緊以及供應鏈的演變如何重新定義緊急通風領域的產品設計選擇和採購優先級

手動人工呼吸器的格局正在被多種變革力量再形成，這些力量正在改變設備的設計、採購和使用方式。材料科學和一次性設備工程的進步正在改變關於一次性使用與重複使用選擇的討論，而新的滅菌通訊協定和環境問題則促使人們更加關注其生命週期的影響。同時，監管審查的加強和臨床指南的更新也要求製造商提供可靠的性能證據和清晰的使用說明，同時也要滿足可追溯性和上市後監管的要求。

供應鏈動態也是變革的關鍵因素，買家和製造商優先考慮多樣化的籌資策略和庫存彈性。分銷管道也在不斷發展，除了傳統的分銷商網路外，數位採購平台和直接供應商關係也越來越受到青睞。臨床醫生的工作流程和培訓計劃正在調整，以融入特定於設備的功能，例如安全裝袋技術以及與輔助氣道設備的整合，這進一步強調了人因工程和清晰標籤檢視的重要性。

整合以臨床醫生為中心的設計、檢驗的滅菌途徑和透明合規性的製造商將在醫療機構中獲得更高的認可度，而規範設備選擇標準的醫療系統將能夠更好地協調臨床結果與營運效率。最終結果是，市場將獎勵設計創新、監管嚴謹性和供應鏈適應性。

評估近期關稅變化和貿易政策調整將如何迫使救生氣道設備的供應鏈重組和籌資策略

影響跨境貿易和進口關稅的政策變化，為製造商、經銷商和醫療保健提供者帶來了新的營運考量。關稅調整和相關的行政措施可能會增加到岸成本，使供應商合約複雜化，並鼓勵企業採取近岸外包或本地籌資策略。企業正在透過審查其供應商組合、合約條款和庫存政策來應對，以保持臨床的連續性，同時應對日益複雜的交易和潛在的利潤壓力。

關稅不僅影響成本，還會影響製造地決策和資本配置。一些製造商正在加大力度，透過本地化部分價值鏈、優先考慮雙重採購安排以及重新設計包裝和產品配置，最大限度地降低關稅的影響。採購團隊也同樣採用更細緻的整體擁有成本分析，將關稅、物流和合規成本納入其中，以便在價格、前置作業時間和供應商韌性之間做出更明智的權衡。

臨床醫生和醫院管理人員受到採購週期和預算限制的影響，這些因素可能會改變採購計劃和設備標準化舉措。為了緩解此類干擾，相關人員正在擴大供應商資格標準，在區域衛生網路之間建立合作協議，並尋求貿易和關稅顧問的明確指導。近期關稅行動的累積效應凸顯了在供應規劃、合約談判和資本部署決策中了解貿易政策的重要性，同時又不損害患者照護的標準。

深度細分主導的洞察揭示了最終用戶環境、產品組合、再處理要求和分銷管道如何影響設備採用

要了解市場行為，需要仔細注意最終用戶、產品形態、營運模式和銷售管道如何影響需求和採用模式。最終使用者環境包括門診中心、緊急醫療服務、家庭醫療保健和醫院，而醫院又進一步細分為私立醫院、公立醫院和教學醫院。每種環境都有其獨特的臨床工作流程、庫存管理實務和採購要求，這些都會影響產品偏好和規格要求。例如，緊急醫療服務優先考慮緊湊、易於操作且在現場條件下性能可靠的設備，而教學醫院則重視堅固耐用且能夠承受反覆訓練、模擬使用以及臨床護理的設備。

產品類型分為成人、嬰兒、新生兒和兒科，每個類別都需要尺寸、壓力釋放功能和材料來滿足患者群體的生理需求。可重複使用器械的特點還包括高壓釜和不可高壓釜的結構，以及再處理工作流程和生命週期的差異。一次性使用器械則分為無菌和非無菌兩種，這會影響在需要嚴格無菌處理的環境中以及優先考慮成本控制和簡化供應鏈的環境中臨床應用。

銷售管道涵蓋直銷、醫院分銷商、線上通路和零售藥局。線上通路包括企業網站和電商門戶，而零售藥局則包括連鎖藥局和獨立藥局。這些管道對訂單處理速度、捆綁服務以及售後服務支援有著不同的期望。直銷能夠實現更緊密的臨床參與和客製化配置，而分銷商則提供廣泛的產品組合和物流專業知識。電商和零售藥局通路擴大了居家醫療客戶和小型買家的管道，他們重視便利性以及透明的退貨和保固政策。整合這些細分維度，可以為整個價值鏈上的相關人員提供對使用者需求、產品開發重點和分銷策略的細緻入微的視角。

區域醫療保健體系結構、法規環境和分銷模式如何推動差異化採用和商業化方法

美洲、歐洲、中東和非洲以及亞太地區的區域動態對臨床實務、監管預期和籌資策略有著不同的影響。在美洲，採購週期通常與大型綜合醫療保健系統和急救醫療服務 (EMS) 網路交叉，因此非常重視與現有設備的互通性以及與供應商簽訂合約的便利性。該地區對緊急準備和災難應變能力的重視，通常會促使人們對經濟高效的可重複使用系統和一次性設備產生興趣，以滿足激增的需求。

在歐洲、中東和非洲，監管協調、多元化的支付方結構以及多樣化的醫院所有權模式影響著產品的選擇和採購時間表。教學醫院和專科醫療中心通常會採用符合嚴格培訓和性能要求的設備，而公立醫院則可能優先考慮符合當地採購法規且經濟高效的解決方案。在亞太地區，醫療基礎設施的快速擴張、公立和私立醫療機構的混合以及對本地製造和分銷管道的重視，共同塑造醫療需求。在亞太地區營運的製造商會留意不同國家/地區滅菌實踐和臨床通訊協定的差異，這些差異會影響產品設計和標籤策略。

這些區域差異導致了不同的供應商合約模式和商業策略。例如，醫院系統複雜的地區可能優先考慮直銷和臨床教育項目，而重視地理覆蓋範圍更廣和零售商通路的地區則可能利用分銷商合作夥伴關係和電子商務策略。認知到這些細微差別可以幫助相關人員根據當地需求和採購行為調整產品系列、監管途徑和供應鏈。

評估影響採購和臨床應用的競爭優勢和策略能力，從全方位服務製造商到利基創新者

市場領導和新興企業在產品開發、品管和商業性執行方面為這一領域帶來了不同的優勢。成熟的製造商通常受益於垂直整合的品質系統、成熟的滅菌驗證以及長期的臨床合作關係，這有助於將其產品納入醫院處方集和緊急醫療服務 (EMS) 規範。這些能力透過對人因工程、臨床醫生培訓計畫和強大的上市後監測流程的投資得到增強，從而減少了產品採用過程中的摩擦，並增強了採購委員會的信心。

規模較小的創新者和利基製造商通常專注於有針對性的改進，例如輕量化材料、提升閥門性能或解決臨床醫生特定痛點的模組化組件。這些公司可以利用與經銷商和臨床培訓中心的策略夥伴關係關係來加速採用並收集實際績效回饋。同時，契約製造製造商和醫療設備組裝也發揮著至關重要的作用，它們使大型公司能夠快速擴大生產規模，滿足多樣化市場的需求，同時保持品管和合規性。

在這種競爭格局中，成功的企業能夠兼顧監管應對力、臨床醫生參與度和供應鏈韌性。他們優先考慮清晰的標籤和使用說明，在適用的情況下投資滅菌驗證，並創建商業模式，以滿足醫院、急診、門診中心和家庭醫療保健提供者的不同購買行為。這種多管齊下的方法既有助於市場准入，又能長期維持用戶滿意度。

醫療設備製造商和供應商可採取的策略性舉措，以提高臨床相關性、增強供應彈性並擴大醫療環境中的可及性

行業領導者應採用整合方法，將以臨床醫生為中心的設計、清晰的監管和敏捷的供應鏈相結合，以保持市場相關性和營運韌性。優先投資人為因素測試和臨床醫生培訓材料，以確保設備即使在高壓力情況下也能直覺使用，並在預期用例中始終保持性能一致。在產品開發過程中，應為可重複使用產品提供嚴格的無菌驗證，並為一次性產品提供清晰的無菌標籤，以減少採用障礙並增強採購信心。

多元化供應商並提高近期庫存的透明度，可以降低貿易政策變化和物流瓶頸帶來的風險。與經銷商和大型醫療系統協商靈活的合約條款，以適應緊急計劃和緊急採購需求。同時，利用電商和零售藥局的關係，觸達家庭醫療保健領域以及重視可及性和快速履約的小型買家。

最後，協調商業和監管團隊，簡化跨司法管轄區的市場准入，並投資於上市後資料收集，以支援持續改善和合規。透過結合實用的臨床檢驗、有彈性的籌資策略和有針對性的上市模式，領導者可以確保持久的供應商關係，並建立能夠適應不斷變化的臨床和政策環境的產品組合。

一種透明、多方法的研究途徑，結合臨床醫生訪談、監管調查和供應鏈分析，以獲取與您的業務相關的資訊

初步研究採用多方法論，整合了相關人員訪談、法規和標準研究以及對臨床實踐指南和醫療設備附加檔的系統性綜述。初步訪談涵蓋了臨床醫生、採購負責人、經銷商高階主管和生產品管經理，以了解實務實務、使用者偏好和採購限制。這些定性見解與官方監管文件、產品使用說明和滅菌驗證報告的審查相結合，以確認臨床預期與技術規範之間的一致性。

次要分析包括分銷模式和供應鏈配置的比較研究，以及已發表的緊急呼吸道管理相關臨床指南和共識聲明的回顧。在可行的情況下，我們查閱了該設備的技術文獻和人為因素研究，以評估設計權衡及其對再處理的影響。我們參考了貿易政策和海關建議，討論了關稅和跨境採購方面的考慮因素，並聘請了物流專家來解讀其對前置作業時間和庫存計劃的影響。

這種混合調查方法強調透明度、可重複性和實用性。它強調定性的深度和跨職能驗證，而非定量的市場估計和預測，旨在為尋求產品策略與商業現實和監管要求相符的臨床採購團隊、製造商和分銷合作夥伴提供可操作的資訊。

摘要設計、無菌處理、法規遵循和供應彈性之間的相互作用，這對於維持緊急氣道設備的臨床使用至關重要

手動人工呼吸器仍然是緊急呼吸護理的基本組成部分，其發展受到技術進步、採購慣例變化以及影響供應鏈和設備選擇的政策發展的影響。相關人員必須平衡臨床表現、再處理要求和配送實際情況，以適應門診中心、急診醫療服務 (EMS)、居家醫療和多樣化的醫院模式。在速度和可靠性至關重要的環境中，對人為因素的關注、無菌驗證和清晰的標籤仍然是區分不同設備的關鍵。

貿易政策和關稅的變化加劇了商業性複雜性，迫使監管、採購和供應鏈團隊更加緊密地合作。積極擁抱採購多元化、合約靈活性和區域監管途徑的製造商和買家將更有能力保持供應的連續性並維護臨床標準。同時，從與醫療保健提供者的直接關係到電子商務和零售藥局的管道，不斷發展的銷售管道創造了擴大覆蓋範圍的機會，同時滿足了醫療保健和消費者市場的獨特需求。

摘要，務實且以臨床醫生為導向的方法，將卓越的設計、合規性和供應鏈彈性融為一體，能夠為企業提供協助。透過專注於這些基本要求，製造商、經銷商和醫療保健提供者可以提高設備的可用性，並確保手動人工呼吸器在每個護理環節繼續發揮至關重要的救生作用。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 將智慧感測器和回饋機制整合到手動復甦設備中可提高患者安全性
  • 感染控制問題推動緊急醫療服務對一次性手動人工呼吸器的需求
  • 開發用於現場應用的具有即時通氣監測功能的可攜式電池供電手動人工呼吸器
  • 手動人工呼吸器採用符合人體工學的輕質材料製成，可提高臨床醫生在長期使用過程中的舒適度。
  • 整合數位監控和資料登錄系統的高級手動人工呼吸器面臨的監管核准挑戰
  • 隨著主要製造商收購智慧人工呼吸器Start-Ups並擴大產品系列，競爭格局正在改變。
  • 全球供應鏈中斷對醫用級手動人工呼吸器零件供應和價格波動的影響

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 手動人工呼吸器市場（按最終用戶）

  • 門診中心
  • 緊急醫療服務
  • 家庭醫療保健
  • 醫院
    • 私立醫院
    • 公立醫院
    • 教學醫院

9. 手動人工呼吸器市場（依產品類型）

  • 成人
  • 嬰兒
  • 新生
  • 孩子們

第 10 章手動人工呼吸器市場（按操作模式）

  • 可重複使用的
    • 高壓釜
    • 請勿高壓釜
  • 一次性的
    • 非無菌
    • 已滅菌

第 11 章：手動人工呼吸器市場（依銷售管道）

  • 直銷
  • 醫院經銷商
  • 線上管道
    • 公司網站
    • 電子商務入口網站
  • 零售藥局
    • 連鎖藥局
    • 獨立藥房

12. 手動人工呼吸器市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章。手動人工呼吸器市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。按國家/地區分類的手動人工呼吸器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Ambu A/S
    • Cardinal Health, Inc.
    • Teleflex Incorporated
    • Vyaire Medical, Inc.
    • Medline Industries, LP
    • Draegerwerk AG & Co. KGaA
    • Nihon Kohden Corporation
    • GE Healthcare Technologies, Inc.
    • Mindray Medical International Limited
    • Becton, Dickinson and Company
Product Code: MRR-ED54C46E8737

The Manual Resuscitators Market is projected to grow by USD 993.63 million at a CAGR of 7.54% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 555.12 million
Estimated Year [2025] USD 597.54 million
Forecast Year [2032] USD 993.63 million
CAGR (%) 7.54%

Clarifying the role of manual resuscitators within modern emergency and inpatient care pathways while highlighting procurement and clinical usability priorities

The manual resuscitator market intersects clinical urgency, manufacturing standards, and evolving health system expectations, demanding clarity for decision-makers across providers, distributors, and manufacturers. Manual resuscitators remain a core emergency intervention device used across care settings for immediate airway management and ventilation support, and recent shifts in clinical guidelines, sterilization practice, and procurement channels have heightened the need for rigorous intelligence. This introduction situates the device within contemporary care pathways and supply chain realities while emphasizing performance, usability, and regulatory alignment as critical determinants of adoption.

Across care environments, manual resuscitators are evaluated not only for their immediate lifesaving capability but also for their ergonomics, material composition, and compatibility with ancillary equipment. Procurement teams now balance durability, reprocessing requirements, and end-user preferences with the imperative to maintain patient safety under varying operating conditions. In parallel, device manufacturers must navigate a complex regulatory landscape and incorporate clinician feedback to refine design, materials, and labeling that improve both efficacy and usability.

This section sets the stage for a deeper exploration of systemic changes shaping demand and supply. It frames the device as an essential clinical complement to advanced ventilatory supports and a critical component of disaster preparedness. By clarifying clinical roles, operational constraints, and procurement considerations, the introduction prepares readers to interpret subsequent analyses on policy impacts, segmentation nuances, regional dynamics, and strategic responses by industry stakeholders.

How material innovations, regulatory tightening, and supply chain evolution are redefining product design choices and procurement priorities in emergency ventilation

The landscape for manual resuscitators has been reshaped by several transformative forces that alter how devices are designed, procured, and used. Advances in materials science and disposable device engineering have shifted conversations about single-use versus reusable options, and emerging sterilization protocols and environmental concerns have amplified attention on lifecycle impacts. Simultaneously, heightened regulatory scrutiny and updated clinical guidelines are prompting manufacturers to demonstrate robust performance evidence and clear instructions for use, while also addressing traceability and post-market surveillance requirements.

Supply chain dynamics constitute another major vector of change, with buyers and manufacturers emphasizing diversified sourcing strategies and inventory resilience. Distribution channels are evolving too, as digital procurement platforms and direct-to-provider relationships gain traction alongside traditional distributor networks. Clinician workflows and training programs have adapted to incorporate device-specific competencies, including safe bagging techniques and integration with adjunct airway equipment, which has reinforced the importance of human factors engineering and clear labeling.

Taken together, these shifts create both opportunity and obligation: manufacturers that integrate clinician-centric design, validated sterilization pathways, and transparent regulatory compliance will find stronger acceptance across care settings, while health systems that codify device selection criteria can better align clinical outcomes with operational efficiency. The net effect is a market that rewards innovation in design, regulatory rigor, and supply chain adaptability.

Assessing how recent tariff changes and trade policy adjustments compel supply chain realignment and procurement strategies for life-saving airway devices

Policy changes affecting cross-border trade and import duties have introduced new operational considerations for manufacturers, distributors, and healthcare providers. Tariff adjustments and associated administrative measures can increase landed costs, complicate supplier contracts, and incentivize nearshoring or regional sourcing strategies. Organizations respond by reassessing supplier portfolios, contract terms, and inventory policies to preserve clinical continuity while managing increased transactional complexity and potential margin pressure.

Beyond cost implications, tariffs influence manufacturing footprint decisions and capital allocation. Some manufacturers have intensified efforts to localize portions of their value chains, prioritize dual-sourcing arrangements, or redesign packaging and product configurations to minimize tariff exposure. Procurement teams are likewise adopting more granular total-cost-of-ownership analyses that incorporate duty, logistics, and compliance overhead, enabling more informed trade-offs between price, lead time, and supplier resilience.

Clinicians and hospital administrators are affected through procurement cycles and budgetary constraints that can alter purchasing timelines and device standardization initiatives. To mitigate these disruptions, stakeholders are expanding supplier qualification criteria, engaging in collaborative contracting across regional health networks, and seeking clarity from trade and customs advisors. The cumulative effect of recent tariff actions underscores the importance of integrating trade policy awareness into supply planning, contract negotiation, and capital deployment decisions without compromising patient care standards.

Deep segmentation-driven insights that reveal how end-user environments, product configurations, reprocessing requirements, and distribution channels shape device adoption

Understanding market behavior requires close attention to how different end users, product forms, modes of operation, and sales channels shape demand and adoption patterns. End-user settings include ambulatory centers, emergency medical services, home healthcare, and hospitals, with hospitals further differentiated into private hospitals, public hospitals, and teaching hospitals; each setting imposes distinct clinical workflows, stocking practices, and purchasing authorities that influence product preferences and specification requirements. For example, emergency medical services prioritize compact, easy-to-operate devices that perform reliably under field conditions, whereas teaching hospitals emphasize devices that are robust for repeated training and simulation use as well as clinical care.

Product-type segmentation spans adult, infant, neonatal, and pediatric devices, with each category demanding tailored sizing, pressure relief features, and materials suited to the physiological needs of the patient population. Mode-of-operation divides offerings into reusable and single-use configurations; reusable devices are further characterized by autoclave-compatible and non-autoclavable constructions that carry differential reprocessing workflows and lifecycle considerations. Single-use options are examined through the lens of sterile and non-sterile variants, which affect clinical adoption in settings that require strict aseptic handling and those that prioritize cost containment and supply chain simplicity.

Sales channels range from direct sales and hospital distributors to online channels and retail pharmacies, with online channels including company websites and e-commerce portals, and retail pharmacies encompassing chain pharmacies and independent pharmacies. These channels present different expectations around order fulfillment speed, bundled service offerings, and after-sales support. Direct sales enable closer clinical engagement and customized configurations, whereas distributors offer breadth of portfolio and logistics expertise. E-commerce and retail pharmacy routes broaden access for home healthcare customers and smaller buyers, emphasizing convenience and transparent returns and warranty policies. Integrating these segmentation dimensions provides a nuanced view of user needs, product development priorities, and distribution strategies for stakeholders across the value chain.

How regional healthcare system structures, regulatory environments, and distribution models drive differentiated adoption and commercialization approaches

Regional dynamics influence clinical practice, regulatory expectations, and sourcing strategies in distinct ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. In the Americas, procurement cycles often intersect with large integrated health systems and EMS networks, which place a premium on device interoperability with existing equipment and straightforward supplier contracting. This region's emphasis on emergency preparedness and disaster response capabilities often drives interest in both reusable systems for cost efficiency and single-use devices to meet surge demands.

Across Europe, Middle East & Africa, regulatory harmonization, diverse payor structures, and varied hospital ownership models affect product selection and procurement timelines. Teaching hospitals and specialized care centers frequently lead in adopting devices that meet exacting training and performance requirements, while public hospitals may prioritize cost-effective solutions that comply with regional procurement rules. In Asia-Pacific, rapid expansion of healthcare infrastructure, a mix of public and private providers, and an emphasis on localized manufacturing and distribution channels shape demand. Manufacturers operating in Asia-Pacific are attentive to variations in sterilization practices and clinical protocols across countries, which influences product design and labeling strategies.

These regional distinctions drive different supplier engagement models and commercial tactics. For instance, companies may prioritize direct sales and clinical education programs in regions with complex hospital systems, while leveraging distributor partnerships and e-commerce strategies where broader geographic coverage and retail access are critical. Recognizing these nuances helps stakeholders align product portfolios, regulatory pathways, and supply chains to regional needs and procurement behaviors.

Evaluating competitive strengths and strategic capabilities from integrated manufacturers to niche innovators that influence procurement and clinical adoption

Market leaders and emerging players bring differing strengths to product development, quality management, and commercial execution in this segment. Established manufacturers often benefit from vertically integrated quality systems, proven sterilization validations, and longstanding clinical relationships that facilitate hospital formulary inclusion and EMS specifications. These capabilities are reinforced by investments in human factors engineering, clinician training programs, and robust post-market surveillance processes that reduce adoption friction and build trust among procurement committees.

Smaller innovators and niche manufacturers frequently focus on targeted improvements such as lightweight materials, enhanced valve performance, and modular components that address specific clinician pain points. These companies may use strategic partnerships with distributors or clinical training centers to accelerate adoption and gather real-world performance feedback. In parallel, contract manufacturers and medical device assemblers play a pivotal role by enabling larger players to scale production rapidly while maintaining quality controls and regulatory compliance for diverse markets.

Across the competitive landscape, successful companies combine regulatory proficiency, clinician engagement, and supply chain resilience. They also prioritize clear labeling and instructions for use, invest in sterilization validation where applicable, and structure commercial models that address the different purchasing behaviors of hospitals, EMS, ambulatory centers, and home healthcare providers. This multifaceted approach supports both market access and long-term user satisfaction.

Actionable strategic moves for device manufacturers and suppliers to sharpen clinical relevance, bolster supply resilience, and expand access across care settings

Industry leaders should adopt an integrated approach that combines clinician-centered design, regulatory clarity, and supply chain agility to maintain market relevance and operational resilience. Prioritize investments in human factors testing and clinician training materials to ensure devices are intuitive in high-stress scenarios and demonstrate consistent performance across intended use cases. Complement product development with robust sterilization validation for reusable offerings and clear sterile labeling for single-use variants to reduce barriers to adoption and support procurement confidence.

Strengthening supplier diversification and near-term inventory visibility will mitigate exposure to trade policy shifts and logistical bottlenecks. Negotiate flexible contract terms with distributors and large health systems that accommodate contingency planning and surge procurement needs. In parallel, expand commercial channels thoughtfully: use direct engagement for institutional customers that require clinical training and customization, while leveraging e-commerce and retail pharmacy relationships to reach home healthcare segments and smaller buyers who prioritize ease of access and rapid fulfillment.

Finally, align commercial and regulatory teams to streamline market entry across jurisdictions, and invest in post-market data collection to support continuous improvement and compliance. By combining practical clinical validation, resilient sourcing strategies, and targeted go-to-market models, leaders can secure durable relationships with providers and position their portfolios to respond to evolving clinical and policy environments.

A transparent multi-method research approach combining clinician interviews, regulatory review, and supply chain analysis to derive operationally relevant intelligence

The research synthesis is grounded in a multi-method approach that integrates primary stakeholder interviews, regulatory and standards reviews, and a systematic evaluation of clinical practice guidelines and device labeling. Primary interviews encompassed clinicians, procurement officers, distributor executives, and manufacturing quality leads to capture operational realities, user preferences, and procurement constraints. These qualitative insights were triangulated with an examination of public regulatory documents, product instructions for use, and sterilization validation reports to ensure alignment between clinical expectations and technical specifications.

Secondary analysis included a comparative study of distribution models and supply chain configurations, along with a review of published clinical guidelines and consensus statements related to emergency airway management. Where available, device technical literature and human factors studies were examined to assess design trade-offs and reprocessing implications. Trade policy and customs advisories were consulted to frame discussions of tariff and cross-border sourcing considerations, and logistics experts were engaged to interpret implications for lead times and inventory planning.

This blended methodology emphasizes transparency, reproducibility, and practical relevance. It focuses on qualitative depth and cross-functional corroboration rather than projecting numerical market estimates, and it is designed to yield actionable intelligence for clinical procurement teams, manufacturers, and distribution partners seeking to align product strategy with operational realities and regulatory obligations.

Summarizing the essential interplay of design, sterilization practice, regulatory alignment, and supply resilience that sustains clinical use of emergency airway devices

Manual resuscitators remain a foundational element of emergency respiratory care, shaped by technological refinements, shifting procurement practices, and policy developments that influence supply chains and device selection. Stakeholders must balance clinical performance, reprocessing requirements, and distribution pragmatics to maintain readiness across ambulatory centers, EMS, home healthcare, and diverse hospital types. Attention to human factors, sterilization validation, and clear labeling will continue to differentiate devices in environments where speed and reliability are paramount.

Trade policy and tariff changes add a layer of commercial complexity that requires closer coordination between regulatory, procurement, and supply chain teams. Manufacturers and buyers who proactively address sourcing diversity, contractual flexibility, and regional regulatory pathways will be better positioned to sustain supply continuity and maintain clinical standards. At the same time, evolving sales channels-from direct institutional relationships to e-commerce and retail pharmacy access-create opportunities to broaden reach while meeting the distinct needs of institutional and consumer markets.

In summary, a pragmatic, clinician-informed approach that integrates design excellence, regulatory diligence, and supply chain resilience will serve organizations well. By focusing on these imperatives, manufacturers, distributors, and healthcare providers can enhance device availability and ensure that manual resuscitators continue to fulfill their essential lifesaving role across care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of smart sensors and feedback mechanisms in manual resuscitator devices for enhanced patient safety
  • 5.2. Rising demand for disposable single-use manual resuscitators in emergency medical services due to infection control concerns
  • 5.3. Development of portable battery-operated manual resuscitators with real-time ventilation monitoring for field applications
  • 5.4. Adoption of ergonomic lightweight materials in manual resuscitator manufacturing for improved clinician comfort during prolonged use
  • 5.5. Regulatory approval challenges for advanced manual resuscitators with integrated digital monitoring and data logging systems
  • 5.6. Competitive landscape shift driven by major manufacturers acquiring smart resuscitator startups to expand product portfolios
  • 5.7. Impact of global supply chain disruptions on availability and pricing volatility of medical-grade manual resuscitator components

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Manual Resuscitators Market, by End User

  • 8.1. Ambulatory Centers
  • 8.2. Emergency Medical Services
  • 8.3. Home Healthcare
  • 8.4. Hospitals
    • 8.4.1. Private Hospitals
    • 8.4.2. Public Hospitals
    • 8.4.3. Teaching Hospitals

9. Manual Resuscitators Market, by Product Type

  • 9.1. Adult
  • 9.2. Infant
  • 9.3. Neonatal
  • 9.4. Pediatric

10. Manual Resuscitators Market, by Mode Of Operation

  • 10.1. Reusable
    • 10.1.1. Autoclavable
    • 10.1.2. Non-Autoclavable
  • 10.2. Single-Use
    • 10.2.1. Non-Sterile
    • 10.2.2. Sterile

11. Manual Resuscitators Market, by Sales Channel

  • 11.1. Direct Sales
  • 11.2. Hospital Distributors
  • 11.3. Online Channels
    • 11.3.1. Company Websites
    • 11.3.2. E-Commerce Portals
  • 11.4. Retail Pharmacies
    • 11.4.1. Chain Pharmacies
    • 11.4.2. Independent Pharmacies

12. Manual Resuscitators Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Manual Resuscitators Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Manual Resuscitators Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Ambu A/S
    • 15.3.2. Cardinal Health, Inc.
    • 15.3.3. Teleflex Incorporated
    • 15.3.4. Vyaire Medical, Inc.
    • 15.3.5. Medline Industries, L.P.
    • 15.3.6. Draegerwerk AG & Co. KGaA
    • 15.3.7. Nihon Kohden Corporation
    • 15.3.8. GE Healthcare Technologies, Inc.
    • 15.3.9. Mindray Medical International Limited
    • 15.3.10. Becton, Dickinson and Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. MANUAL RESUSCITATORS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. MANUAL RESUSCITATORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MANUAL RESUSCITATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 309. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZ